Crinetics Pharmaceuticals

Price & Volume

Stats

52W Range	$24.10-$53.55
Market Cap	$4.5B
Shares Short	14M

Financials

Revenue (12 Mos)	$1.5M
Revenue Growth (YoY)	158.4%
Gross Profit (12 Mos)	-$312M
Diluted EPS	-$4.53

News

Yahoo Finance • 10 days ago

Crinetics Pharmaceuticals to Participate in The 44th Annual J.P. Morgan Healthcare Conference

Yahoo Finance • 17 days ago

Crinetics Announces First Patient Dosed in Pivotal Adult Trial of Atumelnant in Congenital Adrenal Hyperplasia (CAH)

Yahoo Finance • 17 days ago

Crinetics Pharmaceuticals (CRNX) Poised for Transformational Growth in 2026: Piper Sandler

Yahoo Finance • 25 days ago

Crinetics Announces First Patient Dosed in Phase 1/2 Trial Evaluating CRN09682 for the Treatment of Neuroendocrine Tumors and Other Somatostatin Receptor 2-Expressing Tumors

About

CEO	Dr. R. Scott Struthers Ph.D.
Address	6055 Lusk Boulevard, San Diego, CA, United States, 92121
Sector	Healthcare
Industry	Biotechnology
Full-Time Employees	437